Ashley Mcevoy has bought stock on 2 days since Feb 2026

Ashley McEvoy is the President and Chief Executive Officer of Insulet Corporation (PODD), a role she has held since April 2025, succeeding Jim Hollingshead.( In this position, she leads the Acton, Massachusetts-based company, a global leader in automated insulin delivery systems like the Omnipod 5, focusing on advancing diabetes care innovation and global expansion.(

McEvoy brings nearly three decades of healthcare leadership experience, primarily at Johnson & Johnson from 1996 to 2023, where she most recently served as Executive Vice President and Worldwide Chairman of MedTech, overseeing 60,000 employees and over $30 billion in revenue.( During her tenure, she tripled revenue growth from 1.5% to 7.8%, led key acquisitions totaling over $22 billion, and expanded into new markets including heart failure, vision, and robotics; prior roles included Group Chair of Vision and Diabetes Care and Worldwide President of Ethicon.( She currently serves as an independent director on the Procter & Gamble board and previously on the Children’s Hospital of Philadelphia Board of Trustees.(

Written by Perplexity from public sources.